Belgrade, April 4th and 5th 2019. MagBioVin conference “Magnetic nanoparticles and their applications in medicine”
One of the activities envisaged in the MagBioVin project is to organize the final international conference entitled “Magnetic nanoparticles and their applications in medicine.” The conference will be held in the period April 4-5. 2019. The tentative version of the conference schedule can be found here. Besides the presentation of the results of the project and increasing the visibility of the research team from Vinca, the main goal of the conference is to strengthen ties with prominent centers in the world dealing with related issues. The goal is to create the basis for the formation of a research consortium that would jointly appear in the future project cycles of the European Commission.
All lectures at the conference are invited and last for 30 minutes, with a scheduled time for discussion up to 10 minutes. The invited lecturers are prominent scientists from leading universities and institutes from Europe and America. Participation of researchers and students from partner institutes from Europe, representatives of pharmaceutical companies and medical institutions from the country and the environment, as well as colleagues from the local academic community dealing with nanosciences, physics, chemistry, biology and cancer research, is expected. The conference is also important for connecting students of doctoral studies from Serbia with students from abroad.
Invited speakers and abstracts:
1. Robert Ivkov (USA), “The tumor immune microenvironment is reshaped after systemic exposure to magnetic iron oxide nanoparticles: A study in mouse models of breast cancer” (read abstract)
2. Boris Polyak (USA), “Nanomagnetic approaches for vascular healing and cardiac regeneration” (read abstract)
3. Olivier Sandre (France), “Monocore or multicore iron oxide nanoparticles synthesized in polyols and coated with a thermosensitive cell-penetrating peptide” (read abstract)
4. Adriele Pina-Mello (Irland), “Translational requirements for nanotechnology enable medical products” (read abstract)
5. Florence Gazeau (France), “Long term fate of iron oxide nanoparticles in the body: a long and comprehensive survey” (read abstract)
6. Vittoria Raffa (Italy), “Mechanotransduction of axonal growth: a new strategy based on magnetic nanoparticle to promote nerve regeneration” (read abstract)
7. Sanjay Mathur (Germany), “Chemically engineered iron oxide nanocrystals for transport of biomolecules across biological barriers” (read abstract)
8. María del Puerto Morales (Spain), “Magnetic nanoparticles aggregation effects on cellular magnetic hyperthermia” (read abstract)
9. Gerardo Goya (Spain), “On the feasibility of improving heat production in magnetic fluid hyperthermia: the time of topology” (read abstract)
10. David Serantes (Spain), “Taking magnetic hyperthermia and magnetogenetics to the next level: key aspects to address from a basic-physics point of view” (read abstract)
11. Zeljko Prijovic (Project Magbiovin, Serbia), “Magnetic Nanoparticles for Dual Anti-cancer Therapies to Synergize Hyperthermia (MANDATH-SynH)” (read abstract)
12. Victor Kuncser (Romania), “Engineering and optimization of Specific Absorption Rates of Fe oxide nanoparticles in magnetic hyperthermia” (read abstract)
13. Pankhurst Quentin (England), “Biomedical applications of radionuclide-labelled magnetic nanoparticles” (read abstract)
14. Ana Espinosa (Spain), “Thermal therapies mediated by iron oxide-based nanoparticles: quantitative comparison of heat generation, therapeutic efficiency and limitations” (read abstract)
15. Giuseppe Cirillo (Italy), “Functional carbon nanohybrid for improved vectorization of anticancer therapeutics” (read abstract)
16. Holger Gruell (Germany), “Nanoparticles for Molecular Imaging and Therapy” (read abstract)
The book of abstract can be downloaded here (pdf).